होम
एक्सप्लोर
nav.journalClub
ट्रेंडिंग
और
synapse
⌘+K
भाषा
हिन्दी
हिन्दी
Photobiomodulation (PBM) Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Hematopoietic Stem Cell Transplant Patients | Synapse
March 3, 2026
Photobiomodulation (PBM) Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Hematopoietic Stem Cell Transplant Patients
RL
Rachel M Lott
RW
Randy M. Windreich
Key Points
Oropharyngeal mucositis incidence decreased, and PBM therapy showed promise in reducing discomfort.
The reduction in mucositis rates was significant, with some patients experiencing less severe symptoms.
Analysis utilized a prospective observational design, focusing on pediatric patients undergoing stem cell transplants.
Highlights the potential for PBM as an effective intervention for preventing treatment-related complications in children.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Lott et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76084c6e9836116a2d56e
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.702